14 February 2012
Oxford-based cancer therapeutics company Immunocore and Scottish Health Innovations (SHIL) were the winners at the coveted 2011 Genesis Awards, announced at a special Awards Dinner following the conclusion of Genesis 2011.
Harriet Fear, CEO of One Nucleus said that competition was fierce and showed that despite the current economic downturn, there is a wealth of innovation in the UK life sciences sector: “Companies such as Immunocore and SHIL show that innovation is alive and kicking in the UK. One Nucleus wanted to find a way to provide continued practical encouragement and have thus restructured the Genesis Awards. We decided the best way was to reduce the awards to two – BioPharma Innovation and Medtech Innovation – and give them real value. Thus the winners each receive £25,000 worth of pledged benefits from leading One Nucleus members in key areas along the company development chain – a wide range of pivotal support ranging from patenting to regulatory filing and access to potential partners and investors.”
For more information click on the links below:-